Vaginal oestrogen in Ireland | Local tissue changes in the vagina and urinary tract
Local tissue changes in the vagina and urinary tract.
Health / The Compound journalPhoto: Lupus in Saxonia · 2021 · CC BY-SA 4.0 · framed · Illustrative image.
At a glance
Vaginal oestrogen is used for selected genital or urinary symptoms associated with lower oestrogen after menopause. Products can include creams, tablets, pessaries or rings. HSE guide
The Science Behind the Drug
Local tissue changes in the vagina and urinary tract
Oestrogen receptors in tissues around the vagina respond to local treatment. Changes in the epithelium, moisture and local environment can help with symptoms such as dryness and discomfort. Systemic exposure depends on the product and regimen and is generally lower with low-dose local treatment than with systemic HRT. HSE source
What the evidence measures
Follow the particular local symptoms the treatment was chosen for. Persistent pain, bleeding or recurrent urinary symptoms may need assessment for another cause.
Describe the symptoms you want reviewed
| What to check | Why it matters |
|---|---|
| Local symptoms | dryness, irritation or discomfort |
| Other symptoms | record urinary symptoms or any unexpected bleeding |
What if urinary symptoms continue?
Several problems can cause similar urinary symptoms. Keep a short symptom record and discuss the need for assessment, especially if there is pain, fever or bleeding.
When to ask for help or a medication review
Ask about unexplained bleeding and discuss a history of hormone-sensitive cancer or current endocrine treatment with the relevant care team. HSE patient guidance
What local treatment is trying to improve
The goal can be less dryness, irritation or discomfort with daily activities. Vaginal oestrogen acts at tissues that respond to local hormone exposure. It can improve the thickness and local environment of those tissues. Product formulation affects how it is applied and the treatment plan. Record which symptoms change and which remain bothersome, including urinary symptoms where relevant. HSE vaginal oestrogen guidance · Menopause guideline
When the history changes the treatment discussion
Persistent or unexpected bleeding needs assessment. Recurrent urinary symptoms can have other causes and may need separate investigation. If you have a history of breast cancer, especially if you are taking endocrine treatment, bring the exact prescription and discuss options with the relevant care team. Which combination is appropriate depends on the individual’s history and symptoms. Menopause guideline
Check whether a refill has the same form and instructions. The guide to systemic oestrogen formulations explains why tablets, patches and gels used systemically serve a different purpose.
Related guides
Hormone replacement therapy (HRT) · Continuous combined HRT · Sequential combined HRT · Oestrogen tablets, patches, gel and spray · Utrogestan · How to find the Irish patient leaflet
An estriol cream. Image licence.


